NHS & Public Sector Strong NHS and hospital channel presence with ongoing expansion into General Practitioners, offering sales opportunities to supply healthcare products, sterile services, and contract manufacturing for public sector contracts.

Export & Partnerships Active export and collaboration potential evidenced by past partnerships with Serum Institute of India and a diversified product pipeline, presenting opportunities for international distribution deals and co‑branding of vaccines or generics.

Sterile Capacity Significant investment in sterile products facilities indicates capacity to scale sterile injectables and high‑quality formulations, enabling you to pursue sterile contract manufacturing, fill‑finish collaborations, and government vaccine programs.

Product Diversification Existing launches in pediatric and generic formulations (for example Clobazam suspensions) suggest appetite for further specialty and high‑margin dosage forms, enabling upsell into niche markets and hospital‑based dispensing.

Funding & Compliance Government investment and covid‑related contract extensions highlight reliability of long‑term contracts and compliance readiness, providing a stable base for long‑term supply agreements and predictable procurement cycles.